US regulators have approved clinical trials on a “vaccine” for cocaine addiction. The product is called TA-CD, and it works by generating antibodies in the bloodstream which prevent cocaine from crossing into the brain.
TA-CD is produced by British biotechnology corporation Xenova Group Plc. Chief Executive David Oxlade told Reuters that a product to help cocaine users quit could command a good price, since most are “wealthy and well-insured.”
The vaccine could also forcibly administered in conjunction with “drug courts,” as part of a program to ensure that users can’t enjoy their drug of choice.
An “anti-marijuana vaccine” called SR141716 is currently being tested on humans by the US National Institute on Drug Abuse, as a treatment for “marijuana addiction.”
– Xenova Group Plc.: TA-CD
– National Institute of Drug Abuse press release: Potential Medication Can Reduce Effects of Smoked Marijuana in Humans
– Nature Medicine October 2001 press release: Fighting cocaine with marijuana